Pura Vida Investments, LLC Vincerx Pharma, Inc. Transaction History

Pura Vida Investments, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$0.0 - $0.0 $0 - $0	300 Added 0.28%	108,459 $434,000
Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.0 $0 - $0	48,350 Added 80.84%	108,159 $1.1 Million
Q3 2021 Nov 15, 2021	SELL	$0.0 - $0.0 $0 - $0	-154,224 Reduced 72.06%	59,809 $967,000
Q2 2021 Aug 16, 2021	BUY	$0.0 - $27.0 $0 - $1.74 Million	64,517 Added 43.15%	214,033 $2.78 Million
Q1 2021 May 12, 2021	BUY	$22.6 - $31.0 $124,322 - $170,531	5,501 Added 3.82%	149,516 $2.89 Million
Q4 2020 Feb 16, 2021	BUY	$12.85 - $19.95 $1.85 Million - $2.87 Million	144,015 New	144,015 $3.01 Million

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.